Interestingly in different cancer types including lung, hepatocellular carcinoma and head and neck squamous cell carcinoma, the downregulation of survivin was also considered to be part of the mechanism of action of statins (46–48). This evidence concerns the gene BIRC5 and hepatocellular carcinoma.